about
Incorporated in 1978, Biocon is engaged in the manufacture of biotechnology products and research services. The company's business include Generics with diverse portfolio encompasses a wide range of complex molecules, including cardiovascular medicat...
Read More
343.35
-20.85
(-5.72%)
6.1M
NSE+BSE Volume
NSE 08 Aug, 2025 3:31 PM (IST)
Estimates Miss
Biocon's Q1FY26 net profit plunges 95.2% YoY, misses Forecaster estimates by 69.3%
See details